News stories about AmerisourceBergen (NYSE:ABC) have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. AmerisourceBergen earned a coverage optimism score of 0.11 on Accern’s scale. Accern also gave media stories about the company an impact score of 44.8387225017671 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
AmerisourceBergen (NYSE:ABC) traded down $0.75 during midday trading on Friday, reaching $96.61. 1,597,497 shares of the company traded hands, compared to its average volume of 2,070,377. AmerisourceBergen has a 52-week low of $71.90 and a 52-week high of $106.27. The company has a debt-to-equity ratio of 1.61, a current ratio of 0.95 and a quick ratio of 0.50. The stock has a market capitalization of $21,654.97, a price-to-earnings ratio of 20.82, a price-to-earnings-growth ratio of 1.47 and a beta of 1.03.
AmerisourceBergen (NYSE:ABC) last issued its quarterly earnings data on Tuesday, February 6th. The company reported $1.55 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.35 by $0.20. AmerisourceBergen had a net margin of 0.66% and a return on equity of 53.65%. The company had revenue of $40.47 billion during the quarter, compared to the consensus estimate of $40.42 billion. During the same quarter last year, the company earned $1.36 earnings per share. AmerisourceBergen’s revenue for the quarter was up 6.0% on a year-over-year basis. sell-side analysts anticipate that AmerisourceBergen will post 6.58 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Monday, March 5th. Stockholders of record on Tuesday, February 20th were given a dividend of $0.38 per share. This represents a $1.52 dividend on an annualized basis and a dividend yield of 1.57%. The ex-dividend date of this dividend was Friday, February 16th. AmerisourceBergen’s payout ratio is currently 32.76%.
ABC has been the topic of a number of recent analyst reports. Argus increased their price objective on shares of AmerisourceBergen from $93.96 to $115.00 and gave the company a “buy” rating in a research note on Monday, March 5th. Zacks Investment Research cut shares of AmerisourceBergen from a “buy” rating to a “hold” rating in a research note on Wednesday, January 31st. Goldman Sachs raised shares of AmerisourceBergen from a “neutral” rating to a “buy” rating in a research note on Friday, December 15th. Bank of America initiated coverage on shares of AmerisourceBergen in a research note on Tuesday, February 27th. They issued a “buy” rating and a $111.00 price objective on the stock. Finally, Deutsche Bank initiated coverage on shares of AmerisourceBergen in a research note on Monday, December 4th. They issued a “buy” rating and a $97.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company’s stock. AmerisourceBergen presently has an average rating of “Buy” and an average price target of $103.34.
In other AmerisourceBergen news, insider Dale Danilewitz sold 21,500 shares of AmerisourceBergen stock in a transaction on Friday, February 16th. The shares were sold at an average price of $97.30, for a total value of $2,091,950.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Tim G. Guttman sold 11,600 shares of AmerisourceBergen stock in a transaction on Wednesday, January 3rd. The stock was sold at an average price of $93.40, for a total transaction of $1,083,440.00. The disclosure for this sale can be found here. Insiders have sold 156,809 shares of company stock valued at $14,988,589 in the last three months. Corporate insiders own 27.30% of the company’s stock.
WARNING: “AmerisourceBergen (ABC) Given Media Sentiment Rating of 0.11” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States and international copyright laws. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2018/03/16/amerisourcebergen-abc-given-media-sentiment-rating-of-0-11.html.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.